Earnings History Data for Cyclerion Therapeutics (CYCN) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Cyclerion Therapeutics

Cyclerion Therapeutics Inc. is a clinical-stage biopharmaceutical company harnessing the power of sGC pharmacology to discover, develop and commercialize breakthrough treatments for serious and orphan diseases. The company's product pipeline consists of Olinciguat, Praliciguat and IW-6463 which are in clinical stage. Cyclerion Therapeutics Inc. is based in Cambridge, United States.
Release Date Time Est. Time Symbol Name Market Cap (M) Rep. EPS Est. EPS Last years EPS SeekingAlpha Headline Price Change Ext. Hours Price Ext. Hours Change 52 Week Range Volume Avg. Volume Ext. Hours Volume Top Mover
09-08-2022 AH CYCN Cyclerion Therapeutics 39.00 -0.31 -0.34 0.00 Cyclerion Therapeutics reports Q2 results
[8/9/2022 5:18 PM]
0.96 0.01 
(1.05%)
1.02 0.07 
(7.37%)
0.46 - 3.62 237,297 260,000 111
04-05-2022 AH CYCN Cyclerion Therapeutics 32.00 -0.30 -0.36 0.00 Cyclerion Therapeutics reports Q1 results
[5/4/2022 5:40 PM]
0.71 -0.04 
(-5.33%)
0.80 0.05 
(6.27%)
0.66 - 4.86 95,782 116,552 100
09-11-2021 AH CYCN Cyclerion Therapeutics 125.00 -0.26 -0.29 0.00 Cyclerion Therapeutics EPS beats by $0.09, misses on revenue
[11/9/2021 4:54 PM]
2.63 -0.14 
(-5.05%)
2.89 0.12 
(4.33%)
2.08 - 6.90 333,724 270,000 1,701